137 related articles for article (PubMed ID: 38529374)
1. EVA1A, a novel and promising prognostic biomarker in colorectal cancer.
Fan HH; Zhang HJ
Front Oncol; 2024; 14():1333702. PubMed ID: 38529374
[TBL] [Abstract][Full Text] [Related]
2. The clinical significance of CCBE1 expression in human colorectal cancer.
Zhao YR; Liu H; Xiao LM; Jin CG; Zhang ZP; Yang CG
Cancer Manag Res; 2018; 10():6581-6590. PubMed ID: 30555263
[TBL] [Abstract][Full Text] [Related]
3. High expression of meningioma 1 is correlated with reduced survival rates in colorectal cancer patients.
Ho YJ; Liu FC; Chang J; Shi B; Yeh KT; Lin YM; Lu JW
Acta Histochem; 2019 Jul; 121(5):628-637. PubMed ID: 31133374
[TBL] [Abstract][Full Text] [Related]
4. High expression of lncRNA MALAT1 suggests a biomarker of poor prognosis in colorectal cancer.
Zheng HT; Shi DB; Wang YW; Li XX; Xu Y; Tripathi P; Gu WL; Cai GX; Cai SJ
Int J Clin Exp Pathol; 2014; 7(6):3174-81. PubMed ID: 25031737
[TBL] [Abstract][Full Text] [Related]
5. High expression of SLC17A9 correlates with poor prognosis in colorectal cancer.
Yang L; Chen Z; Xiong W; Ren H; Zhai E; Xu K; Yang H; Zhang Z; Ding L; He Y; Song X; Liu J
Hum Pathol; 2019 Feb; 84():62-70. PubMed ID: 30236596
[TBL] [Abstract][Full Text] [Related]
6. [Predictive value of combination detection of tissue Pgp1 expression and preoperative serum CEA level for colorectal cancer].
Wu F; Chen L; Wu W; Jiang B; Su X
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Apr; 20(4):443-449. PubMed ID: 28440527
[TBL] [Abstract][Full Text] [Related]
7. Mapk14 is a Prognostic Biomarker and Correlates with the Clinicopathological Features and Immune Infiltration of Colorectal Cancer.
Wang D; Peng L; Hua L; Li J; Liu Y; Zhou Y
Front Cell Dev Biol; 2022; 10():817800. PubMed ID: 35141222
[No Abstract] [Full Text] [Related]
8. High expression of AMPD2 and obesity are associated with poor prognosis in colorectal cancer.
Wang F; Liu Y; Jiang J; Qin Y; Ge X; Li J; Qi X; Mao Y
Int J Clin Exp Pathol; 2018; 11(1):216-223. PubMed ID: 31938103
[TBL] [Abstract][Full Text] [Related]
9. Preoperative serum carbohydrate antigen 125 level is an independent negative prognostic marker for overall survival in colorectal cancer.
Yang XQ; Li Y; Chen C; Peng CW; Liu SP; Liu Y
Med Oncol; 2011 Sep; 28(3):789-95. PubMed ID: 20373053
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of LBX2 associated with tumor progression and poor prognosis in colorectal cancer.
Huang X; Yang Y; Yang C; Li H; Cheng H; Zheng Y
Oncol Lett; 2020 Jun; 19(6):3751-3760. PubMed ID: 32382328
[TBL] [Abstract][Full Text] [Related]
11. Upregulation of STC2 in colorectal cancer and its clinicopathological significance.
Zhang C; Chen S; Ma X; Yang Q; Su F; Shu X; Xie W; Feng M; Xiong B
Onco Targets Ther; 2019; 12():1249-1258. PubMed ID: 30863092
[TBL] [Abstract][Full Text] [Related]
12. Aberrant expression of stress-induced phosphoprotein 1 in colorectal cancer and its clinicopathologic significance.
Zhang Z; Ren H; Yang L; Zhang X; Liang W; Wu H; Huang L; Kang J; Xu J; Zhai E; Cai S; He Y
Hum Pathol; 2018 Sep; 79():135-143. PubMed ID: 29879402
[TBL] [Abstract][Full Text] [Related]
13. Expression of aquaporin 1, 3 and 5 in colorectal carcinoma: correlation with clinicopathological characteristics and prognosis.
Zhang G; Hao Y; Chen L; Li Z; Gao L; Tian J; Qiao Q; Zhang J
Pathol Oncol Res; 2023; 29():1611179. PubMed ID: 37334171
[No Abstract] [Full Text] [Related]
14. MTUS1 is a promising diagnostic and prognostic biomarker for colorectal cancer.
Cheng LY; Huang MS; Zhong HG; Ru HM; Mo SS; Wei CY; Su ZJ; Mo XW; Yan LH; Tang WZ
World J Surg Oncol; 2022 Aug; 20(1):257. PubMed ID: 35962436
[TBL] [Abstract][Full Text] [Related]
15. Clinical response and prognostic significance of serum miR-497 expression in colorectal cancer.
Zou G; Wang R; Wang M
Cancer Biomark; 2019; 25(1):11-18. PubMed ID: 31006664
[TBL] [Abstract][Full Text] [Related]
16. Colorectal cancer with low SLC35A3 is associated with immune infiltrates and poor prognosis.
Lu S; Sun X; Tang H; Yu J; Wang B; Xiao R; Qu J; Sun F; Deng Z; Li C; Yang P; Yang Z; Rao B
Sci Rep; 2024 Jan; 14(1):329. PubMed ID: 38172565
[TBL] [Abstract][Full Text] [Related]
17. High expression of PFTK1 in cancer cells predicts poor prognosis in colorectal cancer.
Mao Y; Jia Y; Zhu H; Wang W; Jin Q; Huang F; Zhang S; Li X
Mol Med Rep; 2017 Jul; 16(1):224-230. PubMed ID: 28498444
[TBL] [Abstract][Full Text] [Related]
18. Abnormal expression of ABCD3 is an independent prognostic factor for colorectal cancer.
Zhang Y; Zhang Y; Wang J; Yang J; Yang G
Oncol Lett; 2020 May; 19(5):3567-3577. PubMed ID: 32269631
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of microRNA-21 as a biomarker in each Dukes' stage of colorectal cancer.
Fukushima Y; Iinuma H; Tsukamoto M; Matsuda K; Hashiguchi Y
Oncol Rep; 2015 Feb; 33(2):573-82. PubMed ID: 25421755
[TBL] [Abstract][Full Text] [Related]
20. Upregulated CNTN1 is associated with lymph node metastasis and poor prognosis of colorectal cancer.
Li G; Zhang Z; Ge G; Fang K; Zhu J
Cancer Biomark; 2021; 30(2):193-201. PubMed ID: 33104020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]